Roivant Sciences Ltd. (ROIV)
NASDAQ·Healthcare·Biotechnology
$30.41
+0.60%
Mkt Cap $21.87B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (24 analysts)
$31.50
Range $30.00 – $34.00
Implied Upside
+3.6%
Consensus $31.50 vs current $30.41
NASDAQ·Healthcare·Biotechnology
$30.41
+0.60%
Mkt Cap $21.87B
Buy
9
Hold
0
Sell
0
Price Target (24 analysts)
$31.50
Range $30.00 – $34.00
+3.6%
Consensus $31.50 vs current $30.41